The price hike comes as Netflix has been investing heavily in its content, including new ventures into the live events space ...

Streaming services keep raising prices. More consumers are electing ad-supported tiers. And global streaming revenue is ...

Netflix just rolled out another round of subscription price hikes, highlighting a key debate about the streaming giant's long-term pricing power.

Global streaming revenue grew 14% to $157.1 billion in 2025 — tripling from the $50 billion in 2020 during the height of the Covid-19 pandemic, according to Ampere Analysis. The increase was driven in ...

Amazon audiences will be trending on Netflix soon. On Wednesday, Amazon Ads announced that, starting next quarter, US media buyers will be able to tap Amazon Audiences for targeting when they run ...

Netflix has acquired an AI filmmaking startup called InterPositive, according to a report by Variety. This is a company that was founded by actor Ben Affleck back in 2022. Don't worry if you haven't ...

There were many defining moments featured in the months-long battle for the ownership of Warner Bros. Discovery: sit-downs to woo President Trump, high-profile congressional hearings, a brutal bidding ...

The use of AI in Hollywood has turned into a lightning rod, especially as ongoing contract negotiations between major studios and the Writers Guild of America drag on. Earlier this week, the union ...

Some Tennessee lawmakers are pushing a new idea to help fix the state's roads and bridges. Donald Trump issues ultimatum over SAVE Act Loyola University Chicago student shot, killed while walking with ...

For millions of streaming fans, the "End of an Era" arrived this week with a quiet notification that few expected. Netflix has officially pulled the plug on its service for approximately 87 million ...

AdamW: A standard optimizer used to train deep learning models. Muon: A newer optimizer that Netflix found performs better ...

CytomX Therapeutics(NASDAQ:CTMX), a biotech company that develops conditionally activated biologics for cancer treatment, closed Monday at $6.75, up 44.23%. The stock is jumping after releasing Phase ...